Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


PharmaZen notches strong increase in tough export market

PharmaZen notches strong increase in tough export market


3 April 2014 – Biotechnology company PharmaZen Ltd has reported a 38% increase in its annual surplus before tax of $739,114 for the year ended December 31, 2013, despite a challenging environment for exporters.

The result was on turnover of $6,998,599 and compares with a before tax surplus of $537,108 on turnover of $6,685,972 for the previous corresponding period.

Chief executive Craig McIntosh said it was a significant achievement in what was another challenging year for exporters.

He said PharmaZen had set very aggressive timetables for product and capability development as it looked for additional growth areas.

Last year saw the commercial launch of StimuCalä, a clinically proven calcium supplement.

“This is the first time the PharmZen has had branded material in retail markets and it is our first product with patent protection. StimuCalä is the only product on the market clinically proven not to cause spikes in calcium serum levels,” McIntosh said.

During the year, PharmaZen commissioned a state-of-the art fluidised powder blender enabling highly accurate blending at up to 1500kgs per batch.

McIntosh said the unit provided PharmaZen with a significant point of difference over competitors who had smaller, less-accurate ‘homogenizers’ and had already helped secure additional contract business.

After delays caused by a third party, the extraction plant will be commissioned this year and PharmaZen already has customer commitments for use.

“Frustrations that were outside our control with delays to the extraction project have prompted us to switch to a more self sufficient model and we have invested heavily in putting together a pilot plant that will be on a par with the best available in New Zealand,” McIntosh said.

“This provides a significant advantage as we will be able to offer pilot and scale up capacity across a range of technologies which will include spray drying, solvent extraction, freeze drying, and column separation. With this in mind we have bought a new 1000kg freeze dryer to cope with additional volumes and have an option on another larger unit.”

PharmaZen’s traditional freeze drying and vacuum drying technologies will be complemented in 2014 with the installation of a new Spray Dryer which opens up significant new product opportunities, McIntosh said.

“There is no doubt that exchange rates and margins will again prove challenging for 2014. However, through diversification of product range and increased capabilities, PharmaZen is well positioned.”

ENDS


© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news